As of 2026-03-18, the Intrinsic Value of Preveceutical Medical Inc (PREV.CN) is -0.09 CAD. This PREV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Preveceutical Medical Inc is -570.44%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Preveceutical Medical Inc (PREV.CN) is overvalued by 570.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -570.44% |
| DDM - Stable | (0.05) - (0.14) | (0.10) | -578.9% |
| DDM - Multi | (0.02) - (0.05) | (0.03) | -261.3% |
| Market Cap (mil) | 8.80 |
| Beta | -0.03 |
| Outstanding shares (mil) | 440.11 |
| Enterprise Value (mil) | 13.29 |
| Market risk premium | 5.10% |
| Cost of Equity | 10.77% |
| Cost of Debt | 5.00% |
| WACC | 8.82% |